Company News

Ambrosia Announces Groundbreaking MAT Study

In partnership with Nova Southeastern University, Ambrosia will conduct a study on Gabapentin, a controversial medication used in addiction treatment. For the first time, a groundbreaking new study is going to be conducted at a national treatment center. Ambrosia Treatment Center announced this month that they have been selected by Nova Southeastern University to participate

Ambrosia Announces Groundbreaking MAT Study Read More »

Ambrosia Announces 19k Square-Foot Expansion in South New Jersey

Press Release:  Ambrosia Treatment Center has completed construction of a new center, an expansion of their existing Southern New Jersey Campus. The project adds more quality addiction treatment in the Greater Philadelphia area in response to the growing epidemic in the Northeast. This spring, Ambrosia Treatment Center will expand its Medford, New Jersey campus with a

Ambrosia Announces 19k Square-Foot Expansion in South New Jersey Read More »

Addiction News Coverage Up 14% A New Semi-Annual Report

Although addiction is discussed in less than 1% of all media coverage, a nationwide study conducted by Ambrosia Treatment Center shows that amounts to 3,171 news stories per day. The 14% increase in addiction-related coverage in the last 12 months demonstrates a growing awareness of the issue. Addiction only made up 0.6% of all news

Addiction News Coverage Up 14% A New Semi-Annual Report Read More »

Table of Contents
Scroll to Top
Skip to content